3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
3
Advanced Solid Tumor
3
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Advanced Solid Tumour
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
2
somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)-
1
sodium-iodide symporter
1
fludarabine
1
duvelisib
1
cemiplimab
1
X-Rays
1
Specimen Handling
1
Photons
1
Oxaliplatin
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Gemcitabine
1
Disulfides
1
Cyclophosphamide
1
Brentuximab Vedotin
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Peripheral
×
tislelizumab
×
30 days
×
Clear all
No trials found.